EC Number | Cloned (Comment) | Organism |
---|---|---|
2.4.2.10 | expressed in Escherichia coli | Homo sapiens |
2.4.2.10 | expressed in Escherichia coli | Plasmodium falciparum |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.2.10 | (1R,3R,4R)-3-hydroxy-4-(hydroxymethyl)-1-[(4-nitrophenyl)methyl]pyrrolidin-1-ium | - |
Homo sapiens | |
2.4.2.10 | (1R,3R,4R)-3-hydroxy-4-(hydroxymethyl)-1-[(4-nitrophenyl)methyl]pyrrolidin-1-ium | - |
Plasmodium falciparum | |
2.4.2.10 | (1S,3R,4R)-3-hydroxy-4-(hydroxymethyl)-1-[2-(4-nitrophenyl)ethyl]pyrrolidin-1-ium | - |
Homo sapiens | |
2.4.2.10 | (1S,3R,4R)-3-hydroxy-4-(hydroxymethyl)-1-[2-(4-nitrophenyl)ethyl]pyrrolidin-1-ium | - |
Plasmodium falciparum | |
2.4.2.10 | (2R,3R,4S)-1-[2-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-ium | - |
Homo sapiens | |
2.4.2.10 | (2R,3R,4S)-1-[2-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-ium | - |
Plasmodium falciparum | |
2.4.2.10 | (2R,3R,4S)-1-[2-(6-carboxy-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-ium | - |
Homo sapiens | |
2.4.2.10 | (2R,3R,4S)-1-[2-(6-carboxy-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-ium | - |
Plasmodium falciparum | |
2.4.2.10 | (2R,3S)-3-hydroxy-2-(hydroxymethyl)-5-(4-nitrophenyl)pyrrolidin-1-ium | - |
Homo sapiens | |
2.4.2.10 | (2R,3S)-3-hydroxy-2-(hydroxymethyl)-5-(4-nitrophenyl)pyrrolidin-1-ium | - |
Plasmodium falciparum | |
2.4.2.10 | (2S,3S,4R,5R)-2-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-1-ium | - |
Homo sapiens | |
2.4.2.10 | (2S,3S,4R,5R)-2-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-1-ium | - |
Plasmodium falciparum | |
2.4.2.10 | (2S,3S,4R,5R)-2-[(6-cyano-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-1-ium | - |
Homo sapiens | |
2.4.2.10 | (2S,3S,4R,5R)-2-[(6-cyano-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-1-ium | - |
Plasmodium falciparum | |
2.4.2.10 | (3R,4R)-1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-ium | - |
Homo sapiens | |
2.4.2.10 | (3R,4R)-1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-ium | - |
Plasmodium falciparum | |
2.4.2.10 | (3R,4R)-1-[2-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-ium | - |
Homo sapiens | |
2.4.2.10 | (3R,4R)-1-[2-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-ium | - |
Plasmodium falciparum | |
2.4.2.10 | (7R,8R,9S,9aS)-8,9-dihydroxy-7-(hydroxymethyl)-8,9,9a,10-tetrahydro-7H-pyrrolo[1',2':4,5]pyrazino[1,2-c]pyrimidine-1,3,5(2H)-trione | - |
Homo sapiens | |
2.4.2.10 | (7R,8R,9S,9aS)-8,9-dihydroxy-7-(hydroxymethyl)-8,9,9a,10-tetrahydro-7H-pyrrolo[1',2':4,5]pyrazino[1,2-c]pyrimidine-1,3,5(2H)-trione | - |
Plasmodium falciparum | |
2.4.2.10 | 1,3-dihydroxy-N-[(4-nitrophenyl)methyl]propan-2-aminium | - |
Homo sapiens | |
2.4.2.10 | 1,3-dihydroxy-N-[(4-nitrophenyl)methyl]propan-2-aminium | - |
Plasmodium falciparum | |
2.4.2.10 | 1,3-dihydroxy-N-[2-(4-nitrophenyl)ethyl]propan-2-aminium | - |
Homo sapiens | |
2.4.2.10 | 1,3-dihydroxy-N-[2-(4-nitrophenyl)ethyl]propan-2-aminium | - |
Plasmodium falciparum | |
2.4.2.10 | 1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]pyrrolidin-1-ium | - |
Homo sapiens | |
2.4.2.10 | 1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]pyrrolidin-1-ium | - |
Plasmodium falciparum | |
2.4.2.10 | 4-nitrophenyl beta-D-ribose | - |
Homo sapiens | |
2.4.2.10 | 4-nitrophenyl beta-D-ribose | - |
Plasmodium falciparum | |
2.4.2.10 | 4-nitrophenyl beta-D-ribose 5'-phosphate | - |
Homo sapiens | |
2.4.2.10 | 4-nitrophenyl beta-D-ribose 5'-phosphate | - |
Plasmodium falciparum | |
2.4.2.10 | [(2R,3R,4S,5S)-5-(4-carboxypyridin-3-yl)-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | - |
Homo sapiens | |
2.4.2.10 | [(2R,3R,4S,5S)-5-(4-carboxypyridin-3-yl)-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | - |
Plasmodium falciparum | |
2.4.2.10 | [(2R,3R,4S,5S)-5-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | - |
Homo sapiens | |
2.4.2.10 | [(2R,3R,4S,5S)-5-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | - |
Plasmodium falciparum | |
2.4.2.10 | [(2R,3R,4S,5S)-5-[(6-cyano-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | - |
Homo sapiens | |
2.4.2.10 | [(2R,3R,4S,5S)-5-[(6-cyano-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | - |
Plasmodium falciparum | |
2.4.2.10 | [(3R,4R)-1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]-4-hydroxypyrrolidin-1-ium-3-yl]methyl hydrogen phosphate | - |
Homo sapiens | |
2.4.2.10 | [(3R,4R)-1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]-4-hydroxypyrrolidin-1-ium-3-yl]methyl hydrogen phosphate | - |
Plasmodium falciparum | |
2.4.2.10 | [(7R,8R,9S,9aS)-8,9-dihydroxy-1,3,5-trioxo-1,2,3,5,8,9,9a,10-octahydro-7H-pyrrolo[1',2':4,5]pyrazino[1,2-c]pyrimidin-7-yl]methyl hydrogen phosphate | - |
Homo sapiens | |
2.4.2.10 | [(7R,8R,9S,9aS)-8,9-dihydroxy-1,3,5-trioxo-1,2,3,5,8,9,9a,10-octahydro-7H-pyrrolo[1',2':4,5]pyrazino[1,2-c]pyrimidin-7-yl]methyl hydrogen phosphate | - |
Plasmodium falciparum |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.10 | orotate + 5-phospho-alpha-D-ribose 1-diphosphate | Homo sapiens | - |
orotidine 5'-phosphate + diphosphate | - |
? | |
2.4.2.10 | orotate + 5-phospho-alpha-D-ribose 1-diphosphate | Plasmodium falciparum | - |
orotidine 5'-phosphate + diphosphate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.2.10 | Homo sapiens | - |
- |
- |
2.4.2.10 | Plasmodium falciparum | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.10 | orotate + 5-phospho-alpha-D-ribose 1-diphosphate | - |
Homo sapiens | orotidine 5'-phosphate + diphosphate | - |
? | |
2.4.2.10 | orotate + 5-phospho-alpha-D-ribose 1-diphosphate | - |
Plasmodium falciparum | orotidine 5'-phosphate + diphosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.2.10 | OPRT | - |
Homo sapiens |
2.4.2.10 | OPRT | - |
Plasmodium falciparum |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.4.2.10 | 0.00004 | - |
4-nitrophenyl beta-D-ribose 5'-phosphate | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.000041 | - |
4-nitrophenyl beta-D-ribose 5'-phosphate | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.00012 | - |
4-nitrophenyl beta-D-ribose | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.00019 | - |
4-nitrophenyl beta-D-ribose | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.08 | - |
(2R,3R,4S)-1-[2-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.083 | - |
(3R,4R)-1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.09 | - |
[(7R,8R,9S,9aS)-8,9-dihydroxy-1,3,5-trioxo-1,2,3,5,8,9,9a,10-octahydro-7H-pyrrolo[1',2':4,5]pyrazino[1,2-c]pyrimidin-7-yl]methyl hydrogen phosphate | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.11 | - |
(7R,8R,9S,9aS)-8,9-dihydroxy-7-(hydroxymethyl)-8,9,9a,10-tetrahydro-7H-pyrrolo[1',2':4,5]pyrazino[1,2-c]pyrimidine-1,3,5(2H)-trione | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.12 | - |
1,3-dihydroxy-N-[2-(4-nitrophenyl)ethyl]propan-2-aminium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.14 | - |
[(2R,3R,4S,5S)-5-[(6-cyano-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.15 | - |
1,3-dihydroxy-N-[(4-nitrophenyl)methyl]propan-2-aminium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.17 | - |
[(7R,8R,9S,9aS)-8,9-dihydroxy-1,3,5-trioxo-1,2,3,5,8,9,9a,10-octahydro-7H-pyrrolo[1',2':4,5]pyrazino[1,2-c]pyrimidin-7-yl]methyl hydrogen phosphate | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.2 | - |
[(2R,3R,4S,5S)-5-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.2 | - |
(1R,3R,4R)-3-hydroxy-4-(hydroxymethyl)-1-[(4-nitrophenyl)methyl]pyrrolidin-1-ium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.22 | - |
(3R,4R)-1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.23 | - |
(2R,3S)-3-hydroxy-2-(hydroxymethyl)-5-(4-nitrophenyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.23 | - |
(1S,3R,4R)-3-hydroxy-4-(hydroxymethyl)-1-[2-(4-nitrophenyl)ethyl]pyrrolidin-1-ium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.24 | - |
[(3R,4R)-1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]-4-hydroxypyrrolidin-1-ium-3-yl]methyl hydrogen phosphate | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.25 | - |
1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]pyrrolidin-1-ium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.27 | - |
(7R,8R,9S,9aS)-8,9-dihydroxy-7-(hydroxymethyl)-8,9,9a,10-tetrahydro-7H-pyrrolo[1',2':4,5]pyrazino[1,2-c]pyrimidine-1,3,5(2H)-trione | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.27 | - |
(2R,3R,4S)-1-[2-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.29 | - |
(2R,3R,4S)-1-[2-(6-carboxy-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.3 | - |
(2S,3S,4R,5R)-2-[(6-cyano-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.35 | - |
(2S,3S,4R,5R)-2-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.35 | - |
[(2R,3R,4S,5S)-5-[(6-cyano-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.36 | - |
(2S,3S,4R,5R)-2-[(6-cyano-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.37 | - |
[(2R,3R,4S,5S)-5-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.47 | - |
1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]pyrrolidin-1-ium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.48 | - |
(2R,3S)-3-hydroxy-2-(hydroxymethyl)-5-(4-nitrophenyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.5 | - |
[(3R,4R)-1-[(6-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]-4-hydroxypyrrolidin-1-ium-3-yl]methyl hydrogen phosphate | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.5 | - |
1,3-dihydroxy-N-[(4-nitrophenyl)methyl]propan-2-aminium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.51 | - |
1,3-dihydroxy-N-[2-(4-nitrophenyl)ethyl]propan-2-aminium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.52 | - |
(3R,4R)-1-[2-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.53 | - |
(2S,3S,4R,5R)-2-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 0.57 | - |
(1S,3R,4R)-3-hydroxy-4-(hydroxymethyl)-1-[2-(4-nitrophenyl)ethyl]pyrrolidin-1-ium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.69 | - |
(2R,3R,4S)-1-[2-(6-carboxy-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 0.75 | - |
(1R,3R,4R)-3-hydroxy-4-(hydroxymethyl)-1-[(4-nitrophenyl)methyl]pyrrolidin-1-ium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 1.3 | - |
(3R,4R)-1-[2-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethyl]-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-ium | at pH 8.0 and 25°C | Plasmodium falciparum | |
2.4.2.10 | 4.3 | - |
[(2R,3R,4S,5S)-5-(4-carboxypyridin-3-yl)-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | at pH 8.0 and 25°C | Homo sapiens | |
2.4.2.10 | 15.5 | - |
[(2R,3R,4S,5S)-5-(4-carboxypyridin-3-yl)-3,4-dihydroxypyrrolidin-1-ium-2-yl]methyl hydrogen phosphate | at pH 8.0 and 25°C | Plasmodium falciparum |